The pharmaceutical company raised $32.7m after floating at a price far below its range, while Janssen Pharmaceutica took a 17% stake.

Array Biopharma is among the shareholders of the cancer therapeutics developer after striking a development deal in July last year.

The Novo Nordisk-backed cancer drug developer has set a $75m target for its initial public offering and will use the proceeds to fund further research.

GE-backed media company Townsquare, which emerged from the bankruptcy of Regent Communications, plans to go public after raising $144m since 2010.

The healthcare data security system provider has gone public, but at a price considerably below its $115m target.

The Amgen and Celgene-backed biotechnology company, which has raised $72m across two venture rounds, will use the proceeds to advance two product candidates.

The Foxconn and Disney-backed high-definition camera manufacturer saw its stock rise sharply after it floated at the top of its range yesterday.

The Medtronic-backed medical device developer has filed for an $80m IPO, after raising almost $90m in earlier funding.

The Ascension Health-backed ophthalmic treatment developer will use the proceeds to advance its lead product through Phase 2 and 3 clinical trials.